.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Farmers Insurance
Cantor Fitzgerald
McKinsey
Queensland Health
Medtronic
Johnson and Johnson
Fish and Richardson
Teva
Federal Trade Commission

Generated: June 23, 2017

DrugPatentWatch Database Preview

Claims for Patent: 8,536,167

« Back to Dashboard

Claims for Patent: 8,536,167

Title:Methods for treating ophthalmic, otic, or nasal infections
Abstract: The present invention relates to methods for treating an ophthalmic, otic, or nasal infection comprising treating the infected tissue with a composition comprising finafloxacin or a finafloxacin derivative. The present invention also relates to antimicrobial compositions comprising finafloxacin or a finafloxacin derivative. The compositions are suitable for the treatment of ophthalmic, otic, or nasal infections.
Inventor(s): Stroman; David W. (Irving, TX), Chowhan; Masood A. (Arlington, TX), Appell; Kenneth C. (Burleson, TX)
Assignee: Alcon Research, Ltd. (Fort Worth, TX)
Application Number:12/829,973
Patent Claims: 1. A method for treating an ophthalmic, otic, or nasal infection comprising: treating the infection with a pharmaceutically effective amount of a composition comprising finafloxacin at a concentration of 0.1 to 1.0 w/v %.

2. A method according to claim 1 wherein said infection is a nasal infection.

3. A method according to claim 1 wherein said infection is acute otitis externa or acute otitis media with tympanostomy tubes.

4. A method according to claim 1 wherein said composition comprises finafloxacin or a pharmaceutically acceptable salt thereof at a concentration of 0.1 to 0.5 w/v %.

5. A method according to claim 1 wherein said composition comprises finafloxacin or a pharmaceutically acceptable salt thereof at a concentration of 0.3 to 0.4 w/v %.

6. A method according to claim 1, said composition having a pH of 5.0 to 7.5.

7. A method according to claim 1, said composition having a pH of 5.0 to 6.0.

8. A method according to claim 1, said composition further comprising an anti-inflammatory agent.

9. A method according to claim 8 wherein said anti-inflammatory agent is dexamethasone.

10. A method according to claim 1 wherein said infection is an otic infection.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Cerilliant
Colorcon
UBS
Boehringer Ingelheim
Harvard Business School
Express Scripts
Teva
Merck
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot